Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Positive Allosteric Modulation of Native and Recombinant γ-Aminobutyric AcidB Receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its Aldehyde Analog CGP13501

Stephan Urwyler, Johannes Mosbacher, Kurt Lingenhoehl, Jakob Heid, Karin Hofstetter, Wolfgang Froestl, Bernhard Bettler and Klemens Kaupmann
Molecular Pharmacology November 2001, 60 (5) 963-971; DOI: https://doi.org/10.1124/mol.60.5.963
Stephan Urwyler
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes Mosbacher
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kurt Lingenhoehl
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jakob Heid
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karin Hofstetter
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wolfgang Froestl
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bernhard Bettler
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Klemens Kaupmann
Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 60 no. 5 963-971
DOI 
https://doi.org/10.1124/mol.60.5.963
PubMed 
11641424

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received May 15, 2001
  • Accepted July 20, 2001
  • Published online November 1, 2001.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Stephan Urwyler,
  2. Johannes Mosbacher,
  3. Kurt Lingenhoehl,
  4. Jakob Heid,
  5. Karin Hofstetter,
  6. Wolfgang Froestl,
  7. Bernhard Bettler, and
  8. Klemens Kaupmann
  1. Novartis Pharma AG, TA Nervous System, Basel, Switzerland
  1. Dr. Stephan Urwyler, Novartis Pharma AG, TA Nervous System, WKL-125.11.03, CH-4002 Basel, Switzerland. E-mail:stephan.urwyler{at}pharma.novartis.com
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: October 2001 to February 2023

AbstractFullPdf
Oct 20014653159
Nov 200172361
Dec 200131223
Jan 200211417
Feb 200273731
Mar 200252224
Apr 200211310
May 200201923
Jun 200242424
Jul 200224030
Aug 200262538
Sep 20024910
Oct 200261629
Nov 200252725
Dec 2002101818
Jan 200341624
Feb 200361825
Mar 200362438
Apr 2003133926
May 2003102831
Jun 200391623
Jul 2003163726
Aug 200319136
Sep 2003263736
Oct 2003223429
Nov 2003194222
Dec 2003151931
Jan 2004153428
Feb 2004103934
Mar 2004194028
Apr 2004143720
May 2004133616
Jun 2004234518
Jul 2004224218
Aug 2004182819
Sep 2004122411
Oct 2004165020
Nov 2004195323
Dec 200427195
Jan 2005204221
Feb 2005253114
Mar 2005174126
Apr 2005202327
May 2005192920
Jun 200514218
Jul 2005142415
Aug 2005122012
Sep 200593526
Oct 2005203224
Nov 2005204019
Dec 2005122513
Jan 2006163118
Feb 2006162715
Mar 2006123118
Apr 2006132117
May 2006113635
Jun 2006111915
Jul 2006143522
Aug 2006101219
Sep 200681412
Oct 2006121615
Nov 200671513
Dec 20067105
Jan 2007111913
Feb 200791813
Mar 2007171910
Apr 20074139
May 200762412
Jun 2007589
Jul 200771616
Aug 2007101315
Sep 2007274
Oct 200771616
Nov 200771710
Dec 20076612
Jan 200841415
Feb 200821313
Mar 200891613
Apr 200882517
May 2008202717
Jun 2008143517
Jul 2008131418
Aug 200810169
Sep 2008231410
Oct 200813209
Nov 200872115
Dec 20086199
Jan 2009111911
Feb 2009497
Mar 2009201815
Apr 200912146
May 2009676
Jun 20099711
Jul 200912138
Aug 20091576
Sep 200916138
Oct 20091698
Nov 200941110
Dec 2009683
Jan 2010152119
Feb 201062612
Mar 201013911
Apr 2010142117
May 201019119
Jun 2010191513
Jul 20101286
Aug 201011109
Sep 201012179
Oct 201091110
Nov 2010181210
Dec 201012136
Jan 201124117
Feb 2011201419
Mar 2011131510
Apr 2011141811
May 2011182219
Jun 201124610
Jul 2011151721
Aug 201121914
Sep 201133911
Oct 2011382919
Nov 2011291217
Dec 2011241219
Jan 2012181422
Feb 2012261014
Mar 2012331527
Apr 20122499
May 2012181919
Jun 2012131814
Jul 2012191413
Aug 20121358
Sep 2012231311
Oct 2012341718
Nov 2012281618
Dec 2012221713
Jan 2013272321
Feb 201314187
Mar 2013262017
Apr 201324811
May 20133768
Jun 20131155
Jul 20131284
Aug 20131313
Sep 201315813
Oct 2013311211
Nov 2013191313
Dec 201321413
Jan 2014231117
Feb 20141984
Mar 20145810
Apr 2014311116
May 2014511735
Jun 201420915
Jul 2014421615
Aug 201471811
Sep 20141491
Oct 2014251813
Nov 2014224910
Dec 2014105312
Jan 201515177
Feb 20152169
Mar 2015301414
Apr 2015211914
May 20152097
Jun 2015151414
Jul 201591914
Aug 201522122
Sep 2015131810
Oct 20152886
Nov 2015221017
Dec 20151794
Jan 201628912
Feb 201629139
Mar 201633717
Apr 201613710
May 2016151112
Jun 201618919
Jul 2016251211
Aug 201637118
Sep 201640145
Oct 201645156
Nov 201638175
Dec 2016144012
Jan 20174676
Feb 20173417
Mar 20175536
Apr 20178576
May 201773119
Jun 201782515
Jul 201771610
Aug 20177158
Sep 20175177
Oct 201762411
Nov 201793810
Dec 20177273
Jan 201862910
Feb 20186145
Mar 20185305
Apr 201872911
May 20182529
Jun 20180366
Jul 20185197
Aug 20183126
Sep 20180166
Oct 201831011
Nov 20184206
Dec 20182984
Jan 20192222
Feb 20191611
Mar 20193310
Apr 20192223
May 20191510
Jun 20192564
Jul 20191544
Aug 20193022
Sep 20193422
Oct 20193565
Nov 20194600
Dec 20192533
Jan 20201711
Feb 20203762
Mar 20202053
Apr 20202422
May 20201701
Jun 20202010
Jul 20202022
Aug 20201301
Sep 20203000
Oct 20203623
Nov 20204121
Dec 20202820
Jan 202127254
Feb 202118121
Mar 20212963
Apr 20212751
May 20213263
Jun 202127141
Jul 20212991
Aug 202145131
Sep 202139121
Oct 20214641
Nov 20212831
Dec 20213461
Jan 20223632
Feb 202217115
Mar 20221541
Apr 20221792
May 20223163
Jun 20222421
Jul 20223043
Aug 20221410
Sep 20221651
Oct 20223392
Nov 20222220
Dec 20222542
Jan 20233762
Feb 2023610

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 60 (5)
Molecular Pharmacology
Vol. 60, Issue 5
1 Nov 2001
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Positive Allosteric Modulation of Native and Recombinant γ-Aminobutyric AcidB Receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its Aldehyde Analog CGP13501
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Positive Allosteric Modulation of Native and Recombinant γ-Aminobutyric AcidB Receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its Aldehyde Analog CGP13501

Stephan Urwyler, Johannes Mosbacher, Kurt Lingenhoehl, Jakob Heid, Karin Hofstetter, Wolfgang Froestl, Bernhard Bettler and Klemens Kaupmann
Molecular Pharmacology November 1, 2001, 60 (5) 963-971; DOI: https://doi.org/10.1124/mol.60.5.963

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Positive Allosteric Modulation of Native and Recombinant γ-Aminobutyric AcidB Receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its Aldehyde Analog CGP13501

Stephan Urwyler, Johannes Mosbacher, Kurt Lingenhoehl, Jakob Heid, Karin Hofstetter, Wolfgang Froestl, Bernhard Bettler and Klemens Kaupmann
Molecular Pharmacology November 1, 2001, 60 (5) 963-971; DOI: https://doi.org/10.1124/mol.60.5.963
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • The binding site for KCI807 in the androgen receptor
  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics